What are the key details of the contract renewal Pro Medicus (ASX:PME) secured?

Pro Medicus (ASX:PME) announced a five-year contract renewal valued at A$16 million with The Ohio State University Wexner Medical Centre (OSUWMC).

How is the Pro Medicus (ASX:PME) contract structured financially?

The contract is structured on a transaction-based model that offers potential financial upside for Pro Medicus. The terms were successfully negotiated with increased transaction minimums alongside an elevated fee per transaction, ensuring higher baseline revenue compared to the previous agreement.

What is the total value of Pro Medicus (ASX:PME) renewals for the financial year?

With the addition of the OSUWMC deal, Pro Medicus’s total contract renewals for the current financial year have reached A$141 million. Management views this milestone as a strong validation of the company's client retention capabilities and the commercial viability of its software platform.

Why does the OSUWMC contract matter for the Pro Medicus long-term investment thesis?

The renewal demonstrates Pro Medicus's ability to upsell existing clients by integrating new modules like Visage 7 Workflow and Visage 7 Cardiology Imaging. This supports the long-term bull case that the company can expand its average revenue per user (ARPU) within major hospital networks rather than relying solely on new client acquisition.

Who is the client involved in Pro Medicus's (ASX:PME) latest US deal?

The client is The Ohio State University Wexner Medical Centre (OSUWMC), a large multi-disciplinary academic medical centre in Columbus, Ohio. OSUWMC is a major healthcare network employing roughly 22,000 staff and 2,000 physicians while operating over 1,400 inpatient beds across six hospitals.

Image for illustrative purposes only. Not a real photo.

Pro Medicus secures $16M US contract renewal

Written by Brie CarterPublished Jun. 3 2026Last Updated Jun. 3 2026

Pro Medicus (ASX:PME) has secured a major five-year, $16 million contract renewal with The Ohio State University Wexner Medical Centre.

The agreement, finalised through Pro Medicus' wholly-owned US subsidiary, Visage Imaging, expands upon their existing partnership.

The renewed deal incorporates the implementation of the Visage 7 Workflow and Visage 7 Cardiology Imaging platforms.

Based on a transaction-based model with potential upside, the contract was successfully negotiated with increased minimums and an elevated fee per transaction.

OSUWMC is a multi-disciplinary academic medical centre based in Columbus, Ohio.

The institution employs approximately 22,000 staff and 2,000 physicians, supporting over 1,400 inpatient beds across six hospitals whilst serving as the primary teaching hospital for The Ohio State University College of Medicine.

Dr Sam Hupert, CEO of Pro Medicus, stated that the expansion confirms the extensive native capabilities of their technology as clients look to retire legacy solutions and scale the Visage 7 Enterprise Imaging Platform.

According to Dr Hupert, the newest deal brings the company’s total renewals for the financial year to an impressive $141 million.

He emphasised that the transaction maintains Pro Medicus’s track record of client retention and underpins their belief that the solution provides an unparalleled return on investment from both a financial and a clinical perspective.